Literature DB >> 22451953

Retinal angiomatous proliferation in age–related macular degeneration. 2001.

Lawrence A Yannuzzi, Silvana Negrão, Tomohiro Iida, Cynthia Carvalho, Hanna Rodriguez-Coleman, Jason Slakter, K Bailey Freund, John Sorenson, Dennis Orlock, Natalie Borodoker.   

Abstract

BACKGROUND: It is known that choroidal neovascularization (CNV) in age-related macular degeneration (ARMD) may erode through the retinal pigment epithelium, infiltrate the neurosensory retina, and communicate with the retinal circulation in what has been referred to as a retinal–choroidal anastomosis (RCA). This is extremely common in the end stage of disciform disease. In recent years, the reverse also seems to be possible, as angiomatous proliferation originates from the retina and extends posteriorly into the subretinal space, eventually communicating in some cases with choroidal new vessels. This form of neovascular ARMD, termed retinal angiomatous proliferation (RAP) in this article, can be confused with CNV.
PURPOSE: The purpose of this article is 1) to review the clinical and angiographic characteristics of a series of patients with RAP and 2) to propose a theoretical sequence of events that accounts for the neovascularized process.
METHODS: In this retrospective clinical and angiographic analysis, 143 eyes with RAP (108 patients) were reviewed and classified based on their vasogenic nature and course. Clinical biomicroscopic examination, fluorescein angiography, and indocyanine green angiography were used to evaluate patients.
RESULTS: The results of this series suggest that angiomatous proliferation within the retina is the first manifestation of the vasogenic process in this form of neovascular ARMD. Dilated retinal vessels and pre-, intra-, and subretinal hemorrhages and exudate evolve, surrounding the angiomatous proliferation as the process extends into the deep retina and subretinal space. One or more dilated compensatory retinal vessels perfuse and drain the neovascularization, sometimes forming a retinal–retinal anastomosis. Fluorescein angiography in these patients usually revealed indistinct staining simulating occult CNV. Indocyanine green angiography was useful to make an accurate diagnosis in most cases. It revealed a focal area of intense hyperfluorescence corresponding to the neovascularization ("hot spot") and other characteristic findings. Based on understanding of the nature and progression of the neovascularized process, patients with RAP were classified into three vasogenic stages. Stage I involved proliferation of intraretinal capillaries originating from the deep retinal complex (intraretinal neovascularization [IRN]). Stage II was determined by growth of the retinal vessels into the subretinal space (subretinal neovascularization [SRN]). Stage III occurred when CNV could clearly be determined clinically or angiographically. A vascularized pigment epithelial detachment and RCA were inconsistent features of this stage.
CONCLUSIONS: Retinal angiomatous proliferation appears to be a distinct subgroup of neovascular ARMD. It may present in one of three vasogenic stages: IRN, SRN, or CNV. Whereas ICG angiography is helpful in diagnosing RAP and in documenting the stage of the neovascularized process, it is frequently difficult to determine the precise nature and location of the new vessel formation. It is important for clinicians to recognize the vasogenic potential and the associated manifestations of this peculiar form of neovascular ARMD so that a proper diagnosis can be made, and when possible, an appropriate management administered.

Entities:  

Mesh:

Year:  2012        PMID: 22451953     DOI: 10.1097/iae.0b013e31823f9b3b

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  19 in total

1.  [Intravitreal ranibizumab for the treatment of retinal angiomatous proliferation].

Authors:  J Maaß; D Sandner; E Matthé
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

2.  A proof of concept study to evaluate the treatment response of aflibercept in wARMD using OCT-A (Canada study).

Authors:  Simrat K Sodhi; Carmelina Trimboli; Sivaruben Kalaichandran; Austin Pereira; Netan Choudhry
Journal:  Int Ophthalmol       Date:  2021-02-07       Impact factor: 2.031

3.  Nitrite Modification of Extracellular Matrix Alters CD46 Expression and VEGF Release in Human Retinal Pigment Epithelium.

Authors:  Mark A Fields; Hui Cai; Hannah E Bowrey; Ernesto F Moreira; Monika Beck Gooz; Kannan Kunchithapautham; Jie Gong; Emma Vought; Lucian V Del Priore
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

4.  Deletion of SPARC Enhances Retinal Vaso-Obliteration in Mouse Model of Oxygen-Induced Retinopathy.

Authors:  Doaa Sobeih; Khaled A Hussein; Neveen Said; Kouros Motamed; Mohamed Al-Shabrawey
Journal:  HSOA J Ophthalmol Clin Res       Date:  2014-08-22

5.  Neurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant Mice.

Authors:  Verity Johnson; Mengqing Xiang; Zhe Chen; Harald J Junge
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 6.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

Authors:  Ursula Schmidt-Erfurth; Victor Chong; Anat Loewenstein; Michael Larsen; Eric Souied; Reinier Schlingemann; Bora Eldem; Jordi Monés; Gisbert Richard; Francesco Bandello
Journal:  Br J Ophthalmol       Date:  2014-09       Impact factor: 4.638

Review 7.  Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration.

Authors:  Chandrakumar Balaratnasingam; Elona Dhrami-Gavazi; Jesse T McCann; Quraish Ghadiali; K Bailey Freund
Journal:  Clin Ophthalmol       Date:  2015-12-17

8.  Optical Coherence Tomography Angiography versus Dye Angiography in Age-Related Macular Degeneration: Sensitivity and Specificity Analysis.

Authors:  Eleni Nikolopoulou; Massimo Lorusso; Luisa Micelli Ferrari; Maria Vittoria Cicinelli; Francesco Bandello; Giuseppe Querques; Tommaso Micelli Ferrari
Journal:  Biomed Res Int       Date:  2018-03-07       Impact factor: 3.411

9.  Geographic atrophy phenotype identification by cluster analysis.

Authors:  Jordi Monés; Marc Biarnés
Journal:  Br J Ophthalmol       Date:  2017-07-20       Impact factor: 4.638

10.  BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration.

Authors:  Kalonji Ntumba; Naoufal Akla; S Paul Oh; Anne Eichmann; Bruno Larrivée
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.